Treating trans youth: Separating fact from fiction

In recent months, more states have debated and even passed legislation that limits how health care is delivered to transgender individuals. In the last year alone, more than 20 such bills have been enacted nationwide. In Part 1 of this two-part episode (recorded May 16, 2022), we take a closer look at the impact these laws are having on transgender care with a panel of experts at the local, state and federal level. In part 2 (posting June 28) our experts discuss PrEP injectables, the newest treatment and prevention modality for HIV. Joining us for this panel discussion are:  David Rosenthal, DO, PhD, medical director for Northwell’s Center for Transgender Care; as well as medical director for the Center for Young Adult, Adolescent and Pediatric HIV.  Demetre Daskalakis, MD, director of the Division of HIV/AIDS Prevention (DHAP) for the Centers for Disease Control and Prevention (CDC) Charles Gonzalez, MD, medical director for the New York State Department of Health's AIDS Institute More from the experts Dr. Rosenthal shares his perspective as a physician treating transgender individuals on care being politicized and how health care can help.